Brainlab, which earlier this month dealt its orthopedic joint reconstruction assets to Smith & Nephew (NYSE:SNN), is already an investor and markets the Medineering robot-assisted surgical arm under the Cirq brand. The Munich-based company said it plans to fold the Medineering tech into its open-architecture surgery offering.
“Medineering introduced a fresh new approach to surgical robotics when we entered into our partnership less than three years ago,” pesident & CEO Stefan Vilsmeier said in prepared remarks. “Today, we are shifting gears and accelerating development with additional resources to address a broader clinical market.”
“Becoming part of Brainlab means scalability for our technology and improved market access,” added Medineering co-founder & CEO Stephan Nowatschin. “Combining our open platform with the software ecosystem from Brainlab will enable more efficient development of very competitive clinical solutions.”
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.